Fig. 2From: Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network modelMultistage Markov Model built with Markov Influence Diagram and Bayesian NetworkBack to article page